Cardlytics Inc. (CDLX)
Cardlytics Statistics
Share Statistics
Cardlytics has 52.5M shares outstanding. The number of shares has increased by 6.77% in one year.
| 52.5M |
| 6.77% |
| 2.48% |
| 60.62% |
| 49.8M |
| 7,940 |
| 0.95% |
Short Selling Information
The latest short interest is 8.57M, so 16.33% of the outstanding shares have been sold short.
| 8.57M |
| 16.33% |
| 19.07% |
| 13.48 |
Valuation Ratios
The PE ratio is -0.95 and the forward PE ratio is -1.17. Cardlytics's PEG ratio is -0.16.
| -0.95 |
| -1.17 |
| 0.64 |
| 0.3 |
| 2.56 |
| -6.38 |
| -0.16 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cardlytics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 3.17.
| 1.19 |
| 1.19 |
| 3.17 |
| -1.45 |
| -7.88 |
| -21.96 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $632,495.45 |
| $-430,236.36 |
| 440 |
| 0.71 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -77.06% in the last 52 weeks. The beta is 1.26, so Cardlytics's price volatility has been higher than the market average.
| 1.26 |
| -77.06% |
| 1.73 |
| 2.95 |
| 53.79 |
| 837,831 |
Income Statement
In the last 12 months, Cardlytics had revenue of 278.3M and earned -189.3M in profits. Earnings per share was -3.91.
| 278.3M |
| 120.89M |
| -195.5M |
| -189.3M |
| -152.53M |
| -180.4M |
| -3.91 |
Balance Sheet
The company has 65.59M in cash and 221.65M in debt, giving a net cash position of -156.06M.
| 65.59M |
| 221.65M |
| -156.06M |
| -1.3B |
| 369.07M |
| 24.98M |
Cash Flow
In the last 12 months, operating cash flow was -8.82M and capital expenditures -19.3M, giving a free cash flow of -28.12M.
| -8.82M |
| -19.3M |
| -28.12M |
| -0.58 |
Margins
Gross margin is 43.44%, with operating and profit margins of -70.25% and -68.02%.
| 43.44% |
| -70.25% |
| -68.02% |
| -68.02% |
| -54.81% |
| -70.25% |
| -10.1% |
Dividends & Yields
CDLX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CDLX is $3.25, which is 72% higher than the current price. The consensus rating is "Hold".
| $3.25 |
| 72% |
| Hold |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -5.48 |
| 4 |